Paion AG
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation… Read more
Market Cap & Net Worth: Paion AG (PAIOF)
Paion AG (PINK:PAIOF) has a market capitalization of $150.53K ($150.53K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40426 globally and #13117 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paion AG's stock price $0.02 by its total outstanding shares 7526380 (7.53 Million).
Paion AG Market Cap History: 2015 to 2025
Paion AG's market capitalization history from 2015 to 2025. Data shows change from $186.29 Million to $150.53K (-52.66% CAGR).
Paion AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paion AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.91x
Paion AG's market cap is 0.91 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $186.29 Million | $71.61K | -$28.21 Million | 2601.29x | N/A |
| 2016 | $190.69 Million | $4.26 Million | -$20.12 Million | 44.74x | N/A |
| 2017 | $240.32 Million | $5.81 Million | -$12.09 Million | 41.36x | N/A |
| 2018 | $190.78 Million | $2.77 Million | -$9.94 Million | 68.98x | N/A |
| 2019 | $157.51 Million | $8.00 Million | -$7.02 Million | 19.69x | N/A |
| 2020 | $212.96 Million | $19.66 Million | $2.22 Million | 10.84x | 95.84x |
| 2021 | $105.37 Million | $7.13 Million | -$21.79 Million | 14.78x | N/A |
| 2022 | $30.11 Million | $33.25 Million | -$579.00K | 0.91x | N/A |
Competitor Companies of PAIOF by Market Capitalization
Companies near Paion AG in the global market cap rankings as of March 19, 2026.
Key companies related to Paion AG by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Paion AG Historical Marketcap From 2015 to 2025
Between 2015 and today, Paion AG's market cap moved from $186.29 Million to $ 150.53K, with a yearly change of -52.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $150.53K | 0.00% |
| 2024 | $150.53K | 0.00% |
| 2023 | $150.53K | -99.50% |
| 2022 | $30.11 Million | -71.43% |
| 2021 | $105.37 Million | -50.52% |
| 2020 | $212.96 Million | +35.21% |
| 2019 | $157.51 Million | -17.44% |
| 2018 | $190.78 Million | -20.62% |
| 2017 | $240.32 Million | +26.03% |
| 2016 | $190.69 Million | +2.36% |
| 2015 | $186.29 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Paion AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $150.53K USD |
| MoneyControl | $150.53K USD |
| MarketWatch | $150.53K USD |
| marketcap.company | $150.53K USD |
| Reuters | $150.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.